Issue link: https://beckershealthcare.uberflip.com/i/683043
8 PATIENT SAFETY LEADERS policy and communications for over six years. Pascale Carayon, PhD. Proctor & Gamble Bascon Professor in To- tal Quality, Department of Industrial and Systems Engineering at University of Wisconsin-Madison. In addition to her role as a pro- fessor at the University of Wisconsin-Madison, Dr. Carayon directs the university's Center for Quality and Productivity Improvement. She participated on the expert panel that reviewed the Institute of Medicine's "To Err Is Human" report and contributed to the resulting "Free from Harm" patient safety report. She received the Human Factors and Ergonomics Society A.R. Lauer Safety Award in 2015 for her work developing a program to tackle problems related to medical error. She also received the 2015 John M. Eisenberg Patient Safety and Quality Award from the Joint Commission and the National Quality Forum for her use of human factors engineering and the Systems Engineering Initiative for Patient Safety model to advance the patient safety field. Mark R. Chassin, MD. President and CEO of the Joint Commis- sion. In his role at the Joint Commission, Dr. Chassin monitors the activities of the nation's predominant standards-setting and accrediting organization in healthcare. Earlier in his career, Dr. Chassin practiced emergency medicine for 12 years. While at Mount Sinai Medical Cen- ter in New York, Dr. Chassin built a renowned quality improvement program. e goal of the program was to achieve significant improve- ments in every facet of care quality, including safety, clinical outcomes, the experiences of patients and families and the working atmosphere of caregivers. He has been honored with a Founders' Award from the American College of Medical Quality and the Ellwood Individual Award from the Foundation for Accountability. Michael R. Cohen, RPh. President of e Institute for Safe Medication Practices. In addition to his role as president of the ISMP, an organization dedicated to the investigation of medication error causation and the creation of error-reduction strategies, Dr. Cohen serves as the co-editor of the ISMP Medication Safety Alert!, which reaches more than 2 million healthcare professionals. He is a sought-aer medical expert and has appeared on several broadcast and cable television networks, including MSNBC, NPR, CNN and FOX News. Dr. Cohen serves as an advisor to the U.S. Food and Drug Administration's Drug Safety and Risk Management Commit- tee. In 2005 he was named a MacArthur Fellow by the John D. and Catherine T. MacArthur Foundation. Patrick Conway, MD. Deputy Administrator for Innovation & Quality for CMS and CMO of CMS. e offices led by Dr. Conway — the Center for Clinical Standards and Quality and the Center for Medicare and Medicaid Innovation — are responsible for all quality measures for CMS. e offices are a major force for quality and transformation throughout the U.S. healthcare system. From 2007 to 2008, Dr. Conway was a White House fellow assigned to the Office of Secretary in HHS and the director of the Agency for Healthcare Research and Quality. Dr. Conway has published numerous articles in periodicals like JAMA, New England Journal of Medicine and Pe- diatrics. He has also given national presentations on quality of care. Dr. Conway has been previously honored with the HHS Secretary's Award for Distinguished Service — the secretary's highest distinc- tion of excellence. Sara Cosgrove, MD. President-Elect of Society for Healthcare Epidemiology of America. In addition to her position at SHEA, Dr. Cosgrove serves as the director of the antimicrobial stewardship program and the associate hospital epidemiologist at Johns Hopkins Hospital in Baltimore. Dr. Cosgrove was recognized in 2014 with the prestigious Oswald Avery Award from the Infectious Disease Society of America, which is presented to individuals 45 or younger for outstanding early achievement in infectious disease research. Dr. Cosgrove also served as a contributor in the Working Group on Antimicrobial Resistance, a part of the President's Council of Advisors on Science and Technology. Dr. Cosgrove's group provided expert guidance to President Barack Obama on confronting the issue of antimicrobial resistance. Helen Darling. Interim President and CEO of the National Quality Forum. Ms. Darling's career has been centered on finding pragmatic solutions to the problems created by rapidly increas- ing healthcare costs. Before being named interim president, Ms. Darling led the NQF's board for four years. Ms. Darling has been the recipient of many awards, including the President's Award from the American College of Occupational and Environmental Medicine in 2010. She is a sought-aer expert in the subject of healthcare afford- ability and is quoted extensively in national publications like the New York Times, Wall Street Journal, e Economist, Washington Post, Los Angeles Times, Business Insurance and many others. Susan A. Dolan, RN. President of Association for Professionals in Infection Control and Epidemiology. In addition to her role as APIC president, Ms. Dolan is the hospital epidemiologist at Children's Hospital Colorado in Aurora. In her 20-plus-year career, Ms. Dolan has authored more than 30 peer-reviewed publications on a variety of topics regarding infection control and epidemiology, including pediatric neurosurgical shunt infections, pediatric Clos- tridium difficile infections, injection safety and infection control in anesthesia. In the course of her career, Ms. Dolan has received numerous honors, including the APIC Hero of Infection Prevention Award in 2006, the APIC President's Distinguished Service Award in 2012 and the Medical Staff Excellence in Quality and Patient Safety Award from Colorado Children's, among others. Tom Frieden, MD. Director of the Centers for Disease Control and Prevention. Dr. Frieden was named director of the CDC in 2009 by President Barack Obama. In that role, he leads the nation's efforts to control health threats from infectious diseases. Earlier in his career, Dr. Frieden made a name for himself in tuberculo- sis control with the New York City Health Department. ere Dr. Frieden led a program that rapidly reduced TB, including cases of multidrug-resistant TB, by 80 percent. He became a household name in 2014 as the CDC responded to the Ebola outbreak. In 2016, Dr. Frieden continues to be a vocal public figure as the CDC addresses the potential threat of the Zika virus to U.S. residents. Karen Frush, MD. Vice President of Quality of LifePoint Health (Brentwood, Tenn.). Dr. Frush graduated summa cum laude from University of Pittsburgh School of Nursing in 1981, and from the Duke University School of Medicine in Durham, N.C., in 1986. In 1992, Dr. Frush returned to Duke where she is currently an associate professor of pediatrics and an assistant professor in the school of nursing. Dr. Frush finished the National Patient Safety Leadership Fellowship program and was subsequently named chief patient safety officer of the Duke University Health System in November 2004. Dr. Frush was the first pediatrician to be named to the North Carolina State Emergency Medical Services advisory board. She served the board for 11 years. Tejal K. Gandhi, MD. President and CEO of the National Patient Safety Foundation. Before leading the NPSF, Dr. Gandhi was the ex- ecutive director of quality and safety at Brigham and Women's Hos- pital in Boston for 10 years. ere, she worked to optimize systems to reduce medical errors and improve quality of care. Dr. Gandhi has been dedicated to educating clinicians on the issue of patient safety